【FINTEC 0150 交流专区】（前名 ASIABIO）

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) • SUBSCRIPTION OF PLACEMENT SHARES IN VSOLAR GROUP BERHAD (FORMERLY KNOWN AS FAST TRACK SOLUTION HOLDINGS BERHAD) (“VSOLAR”)
We refer to the Company's announcement made on 1 August 2014, the Board of Directors of the Company wishes to add the financial effects on the net assets per share and as such, the statement should read as follows: 5. FINANCIAL EFFECTS The Subscription is not expected to have any material effect on the earnings per share, net assets per share, dividend policy, gearing, share capital and the substantial shareholders' shareholdings of the ABT Group for the financial year ending 31 January 2015. This announcement is dated 7 August 2014.

dada112

这股现在来的时机不是时机...唉。。。

icy97

ASIA BRANDS BERHAD

Type	Announcement
Subject	OTHERS
Description	-DISPOSAL OF SHARES IN WHOLLY-OWNED SUB-SUBSIDIARY, AIMB COTTONSHOP SDN. BHD. TO AUDREY SDN. BHD. ANOTHER WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
Persuant to Paragraph 9.19(24) of Bursa Malaysia Securities Berhad Main Market Listing Requirements, the Board of Directors of the Company wishes to announce that Mickey Junior Sdn. Bhd., a wholly-owned subsidiary of the Company, had on 2 September 2014 disposed off the entire shares held in its wholly-owned subsidiary company, AIMB Cottonshop Sdn. Bhd. ("AIMB") comprising two (2) ordinary shares of RM1.00 each, representing 100% of the total paid-up capital in AIMB at a total consideration of RM2.00 to Audrey Sdn. Bhd., another wholly-owned subsidiary company of the Company. As a result, AIMB  ceased to become a wholly-owned subsidiary of Mickey Junior Sdn. Bhd. and became a wholly-owned subsidiary of Audrey Sdn. Bhd. which shall remain the wholly-owned sub-subsidiary of the Company. The above transaction is not expected to have any material effects on the earnings or net assets of the Company for the financial year ending 31 March 2015. This announcement is dated 2 September 2014.

chloetee820

icy97 发表于 7-9-2014 04:19 AM

这消息会有什么影响股价吗？

APULA

玛拉增持至6.94% 晋亚洲生化大股东

财经新闻 财经  2014-09-26 10:58
（吉隆坡25日讯）玛拉投资（Pelaburan Mara）增持亚洲生化（ASIABIO，0150，创业板）股权至6.94%，晋升为公司大股东。

次季净亏216万公司今日向大马交易所报备，玛拉投资在上周三收购公司的1832万3900股或2.18%股权，持股权因而增至5832万3900股，或6.94%股权。

此外，亚洲生化截至7月31日次季净亏扩大至216万1000令吉或每股0.51仙，上财年同期为134万7000令吉或每股亏损0.32仙。

虽然次季营业额按年激增29倍，达1841万4000令吉。

累积首半年，该公司净亏167万2000令吉，或每股0.39仙；营业额则增27倍，至1854万7000令吉。【南洋网财经】

Notice of Interest Sub. S-hldr (29A)

ASIA BIOENERGY TECHNOLOGIES BERHAD

Particulars of Substantial Securities Holder

Name	Pelaburan MARA Berhad
Address	Suite C-5-4, Wisma Goshen, Plaza Pantai Jalan Pantai Baharu, 59200 Kuala Lumpur
NRIC/Passport No/Company No.	7240-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Name & address of registered holder	Pelaburan MARA Berhad Suite C-5-4, Wisma Goshen, Plaza Pantai Jalan Pantai Baharu, 59200 Kuala Lumpur

Date interest acquired & no of securities acquired
Currency	Malaysian Ringgit (MYR)
Date interest acquired	17/09/2014
No of securities	18,323,900
Circumstances by reason of which Securities Holder has interest	Open Market Acquisition
Nature of interest	Direct
Price Transacted ($$)
Total no of securities after change
Direct (units)	58,323,900
Direct (%)	6.94
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	24/09/2014

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/07/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/07/2014	31/07/2013	31/07/2014	31/07/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	18,414	612	18,547	664
2	Profit/(loss) before tax	-2,164	-1,377	-1,695	938
3	Profit/(loss) for the period	-2,164	-1,377	-1,695	938
4	Profit/(loss) attributable to ordinary equity holders of the parent	-2,161	-1,347	-1,672	994
5	Basic earnings/(loss) per share (Subunit)	-0.51	-0.32	-0.39	0.24
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0759		0.0559

宝翎

这个应该有机会吧。我看mara都进场了

kentg03

为什么没有 profit 可是会上升的

icy97

Date of change	07/10/2014
Name	Tengku Ahmad Badli Shah Bin Raja Hussin
Age	44
Nationality	Malaysian
Type of change	Appointment
Designation	Non-Executive Director
Directorate	Non Independent & Non Executive
Qualifications	Bachelor of Law degree (LLB Hons) from University of East Anglia United Kingdom
Working experience and occupation	Tengku Badli has extensive years’ of exposure in the financial industry sector. He started his career as a Management Trainee in Hongkong and Shanghai Banking Corporation, Hong Kong (“HSBC”) in 1994 and continued his stint with HSBC Group in various senior positions covering both corporate and commercial as well as retail & consumer banking division. He later pursued his career with Kuwait Finance House (Malaysia) Berhad in February 2008 as Head of Branch Management prior to joining Pelaburan Mara Berhad in September 2013. He is also actively involved in serving the society. He was commissioned by SPB Yang Di Pertuan Agong as Major (Honorary) of Regimen 506AW, Angkatan Tentera Malaysia on 8 June 2011 and appointed as Justice of The Peace by The Sultan of Kelantan on 11 November 2012. He is also currently serving as the Deputy President of Malaysia Chess Federation (MCF), the principal authority/sports body for Chess in Malaysia, in affiliation with the world governing body, FIDE.
Directorship of public companies (if any)	PMB Tijari Berhad

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD - ACQUISITION OF SHARES IN FOCUS DYNAMICS TECHNOLOGIES BERHAD
Pursuant to Rule 9.19(26) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that Asiabio Capital Sdn Bhd, a wholly owned subsidiary of the Company, has acquired 18,000,000 shares in Focus Dynamics Technologies Berhad (“FDTB”) from 8 October 2014 to 10 October 2014 amounted to RM1,850,000 which represents 5.1% of the issued and paid-up capital (excluding treasury shares) of FDTB. This announcement is dated 10 October 2014.

icy97

Name	Pelaburan MARA Berhad
Address	Suite C-5-4, Wisma Goshen, Plaza Pantai Jalan Pantai Baharu, 59200 Kuala Lumpur
NRIC/Passport No/Company No.	7240-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Name & address of registered holder	Pelaburan MARA Berhad Suite C-5-4, Wisma Goshen, Plaza Pantai Jalan Pantai Baharu, 59200 Kuala Lumpur

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Date of change	No of securities	Price Transacted (RM)
Acquired	14/10/2014	10,676,100	0.170
Acquired	15/10/2014	15,000,000	0.175

Circumstances by reason of which change has occurred	Open Market Acquisition
Nature of interest	Direct
Direct (units)	84,000,000
Direct (%)	10
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	84,000,000
Date of notice	16/10/2014

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ACQUISITION OF SHELF COMPANY
Asia Bioenergy Technologies Berhad ("the Company” or “ABT”) wishes to announce that it has acquired the entire shares of a shelf private limited company incorporated in Malaysia known as Virgin Hill Sdn Bhd (“VHSB”) at a total cash consideration of RM2.00 (“Acquisition”). VHSB was incorporated on 10 October 2014 with an authorised and paid up share capital of RM400,000 and RM2.00, respectively. VHSB has not commenced operations since its incorporation. The Acquisition does not have any effect on the issued and paid up share capital and major shareholdings structure of ABT and do not have a material effect on the net assets and earnings of the ABT Group. None of the Directors and/or major shareholders of the Company or persons connected with them have any interest, direct or indirect, in the Acquisition. The Acquisition is not subject to the approval of the shareholders of ABT or any relevant government authorities. Having considered all aspects of the Acquisition, the Board of Directors of ABT is of the opinion that the Acquisition is in the best interest of ABT. This announcement is dated 4th day of November, 2014.

icy97

Date of change	24/11/2014
Name	Leung Kok Keong
Age	47
Nationality	Malaysian
Type of change	Appointment
Designation	Executive Director
Directorate	Executive
Qualifications	1. Certified Practising Accountant & Chartered Accountant, CPA Australia & Malaysian Institute of Accountants (1993) 2. Bachelor Degree in Accounting, Curtin University of Technology, Australia (1989)
Working experience and occupation	1. Chief Financial Officer, Iskandar Waterfront Holdings Group, Johor Bahru (September 2013 to present) 2. Director, Acritaz Group, Selangor (January 2010 to present) 3. Executive Director/Executive Chairman, Asia Bioenergy Technologies Berhad, Selangor (May 2009 to September 2012) 4. Independent Non-Executive Director, Kulim Malaysia Berhad, Johor (2011 to present) 5. Independent Non-Executive Director, Damansara Realty Berhad, Kuala Lumpur (2011 to June 2014) 6. Independent Non-Executive Director, Iskandar Waterfront City Berhad, Johor (2010 to September 2013) 7. Chief Executive Officer, Graphene Nanochem PLC, London (September 2006 to February 2008) 8. Executive Director, Newfields Advisors Sdn Bhd, Kuala Lumpur (August 2001 to August 2006)
Directorship of public companies (if any)	Kulim (Malaysia) Berhad
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Direct interest of 50 ordinary shares of RM0.10 each in Asia Bioenergy Technologies Berhad

Date of change	24/11/2014
Name	Looi Kem Loong
Age	38
Nationality	Malaysian
Type of change	Redesignation
Previous Position	Executive Director
New Position	Non-Executive Director
Directorate	Non Independent & Non Executive

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/10/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/10/2014	31/10/2013	31/10/2014	31/10/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	17,555	770	36,102	1,434
2	Profit/(loss) before tax	384	-1,914	-1,311	-976
3	Profit/(loss) for the period	384	-1,915	-1,311	-977
4	Profit/(loss) attributable to ordinary equity holders of the parent	394	-1,908	-1,278	-914
5	Basic earnings/(loss) per share (Subunit)	0.09	-0.48	-0.30	-0.23
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0764		0.0559

APULA

亞洲生物能源 重大宣佈今停牌
財經26 Jan 2015 23:00
http://www.chinapress.com.my/node/595186

（吉隆坡26日訊）亞洲生物能源（ASIABIO，0150，創業板貿服）將在明日（27日）上午9時至中午12時半暫停交易，以針對顯著企業活動進行宣布。

該公司向馬證交所報備，將在早盤暫停交易進行重大宣布。

亞洲生物能源將召開記者會，配合完成簽署顯著企業活動儀式。這項活動將對亞洲生物能源營業額和淨利作出正面公司，這是基于該公司將進行新領域。同時，公司管理層也會公布盈利前景和未來商業策略。

截至今日閉市，亞洲生物能源報19仙，升0.5仙，成交量3007萬9500股。

ype	Announcement
Subject	SUSPENSION OF SECURITIES
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR “COMPANY”) - REQUEST FOR SUSPENSION OF TRADING
ASIABIO wishes to announce that the Company had on 26 January 2015 requested for a suspension of trading of its securities for half (1/2) market day, that is, from 9.00 a.m. to 12.30 p.m. on Tuesday, 27 January 2015 pending the release of a material announcement. The request for suspension is made under subparagraph 3.1(b) of Guidance Note 12 of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad. This announcement is dated 26 January 2015.

宝翎

APULA 发表于 26-1-2015 07:14 PM
亞洲生物能源 重大宣佈今停牌
財經26 Jan 2015 23:00
http://www.chinapress.com.my/node/595186

APULA这对0150是好消息还是坏消息呀

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”) - HEADS OF AGREEMENT IN RELATION TO THE PROPOSED ACQUISITION OF SEMUA SHIPPING SDN BHD (“SSSB”) AND SEMADO MARITIME SDN BHD (“SMSB”)
The Board of Directors of ASIABIO wishes to announce that the Company has on 27 January 2015 entered into a Heads of Agreement (“HOA”) with Hoe Leong Corporation Ltd. (“HLCL”), Sumatec Resources Berhad (“SRB”) and Reachmont Logistics Sdn Bhd (“RLSB”) (collectively referred to as “Parties”) in relation to a series of transactions which will ultimately facilitate the acquisitions of SSSB and SMSB by Asiabio (“Proposed Transactions”). Pursuant to the HOA, ASIABIO and HLCL, SRB and RLSB have jointly agreed to discuss exclusively in good faith the detailed terms and conditions of the Proposed Transactions with the intention to finalise and enter into a definitive agreement within three (3) months from the date of HOA or such other date as the Parties may mutually agree upon. SSSB was incorporated as an exempt private company on 24 April 1980. It has an authorised share capital of RM1,500,000 comprising 1,500,000 ordinary shares, all of which have been issued and credited as fully paid-up. SMSB was incorporated as a private limited company on 25 November 2000. The authorised share capital of SMSB is RM15,000,000 comprising 15,000,000 ordinary shares, of which 11,400,000 shares have been issued and credited as fully paid-up. SSSB and SMSB are in the business of shipping and provision of shipping-related services. Both SSSB and SMSB, respectively currently owned five (5) and three (3) oil tankers and vessels. SSSB and SMSB are both wholly-owned subsidiaries of Semua International Sdn. Bhd., an associated company of SRB and an investee company of HLCL. The other salient terms of the HOA include that the Parties shall not enter into any discussions or negotiations in any manner whatsoever with any other third party which will adversely affect the Proposed Transactions nor enter into any discussions or negotiations or give access or information to any third party with a view to such discussions or negotiations. A detailed announcement on the Proposed Transactions will be made upon the execution of the Definitive Agreement(s). The HOA may be inspected at the registered office of Asiabio at 10th Floor, Menara Hap Seng, No. 1 & 3 Jalan P. Ramlee, 50250 Kuala Lumpur during normal business hours from Mondays to Fridays (except public holidays) for a period of three (3) months from the date of this announcement. This announcement is dated 27 January 2015.

APULA

Rm0.225........,但Focus.....整大堆等卖

leow8686

但是儿子不会起

APULA

发1.68亿股购2物流公司 亚洲生化进军油气下游业
财经新闻 财经  2015-01-28 08:26
http://www.nanyang.com/node/678011?tid=462

（吉隆坡27日讯）亚洲生化（ASIABIO，0150，创业板）将通过发行总值1.68亿令吉的股票，收购两家油气物流公司，进军油气下游业。

配合收购计划，亚洲生化今天与幸马泰资源（SUMATEC，1201，主板贸服股）、和隆集团（HoeLeong），以及Reachmont物流，签署暂定协议（HOA）。

根据协议，两家油气物流公司Semua船运和Semado海事，将被注入特别用途公司（SPV）。

SPV的股东分别是和隆集团、Reachmont物流，以及Ebony Ritz公司。

亚洲生化将以发行总值1.68亿令吉的股票，收购SPV所有股权。

亚洲生化执行董事陈石义今天在记者会上表示，以收购价粗略估算，发行股票总额将占缴足资本逾20%。

SPV股东将持股逾20%

这意味着，SPV的股东会联合持股超过20%，高于亚洲生化目前的大股东，即香港CPE Growth Capital的11.13%，以及玛拉投资（Pelaburan Mara）的10%。

他指出，1.68亿令吉只是目前暂定价格，非最终收购价，因公司接下来还会进行精密审核程序。

他提到，公司策略是科技育成业者（Technology Incubator）和再生能源，但发现股东难以获得短期回酬。

“我们如今选择（收购）油气相关公司，希望可提供回酬给股东。我们投资的公司，有刚起步和发展中的业务，而我们需要有现在就带来回酬的业务。”

陈石义强调，这两家公司是油气物流公司，运输石油产品，占总供应链成本最高50%，但油价降低会把幅度缩减至最低30%。

“油价下滑，让运输产品的成本变得更廉宜……现在，就是公司要进军油气相关产品的最佳机会。”

2015盈利担保1400万

根据文告，SPV将在2014财年录得800万令吉的净利，预估2015财年增至1400万令吉。

若2015财年盈利无法达标，SPV的股东将支付盈利差异，予亚洲生化。

Reachmont物流董事黄雪华提到，两家油气物流公司有总值约2亿令吉的合约在手，接下来也会继续竞标。

Semua船运和Semado海事为Semua国际独资子公司，后者股东为幸马泰资源及和隆集团。

投资控股仍是主要业务

陈石义表示，油气物流业务只是亚洲生化旗下其中一个业务，投资控股依然会是公司主要业务。

他透露，公司目前减持一些表现欠佳的投资，希望有助于转亏为盈。

截至去年10月杪的第三季，公司录得39万令吉净利，上财年同期则是蒙受190万令吉净亏。

针对绿化科技业务，他称进展顺利，接下来还会继续发展新微生物添加剂（microbial supplement）和木材相关业务。

他也提到，已为燃料生产厂寻获数个伙伴，供应原料制造绿化汽油，但美国系统伙伴需要调整一些程序，加上油价下滑，公司暂时未确定下一步行动。

亚洲生化去年2月与美国Cool Planet能源系统合作，利用科技和生物原料，生产具有高辛烷值的RON105。

亚洲生化执行董事梁国强、和隆集团（Hoe Leong）主席兼总执行长柯毓麟，亦列席今天的记者会。

盘中飙18%

配合最新宣布，该股今天早盘暂停交易，下午2时30分恢复交易后，股价急剧攀升。

闭市时，亚洲生化报21仙，一度飙涨18%，最终起2仙或10.5%，成交量有7216万4000股。【南洋网财经】